Regulation of dopamine-induced natriuresis by the dopamine-metabolizing enzyme catechol-O-methyltransferase

Experimental Nephrology

Volumn 7, Issue 4, 1999, Pages 314-322

  Odlind, Cecilia ^a   Göransson, Viktoria ^a   Reenilä, Ilkka ^b   Hansell, Peter ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

COMT; DOPAC; Dopamine; Dopamine receptors; Entacapone; Kidney; L dopa; Sodium

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CATECHOL METHYLTRANSFERASE; DOPAMINE RECEPTOR; ENTACAPONE; LEVODOPA; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; EXTRACELLULAR FLUID; GLOMERULUS FILTRATION RATE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SODIUM TRANSPORT;

EID: 0345085525     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020619     Document Type: Article

References (41)

1. Patschan O, Kuttler B, Heemann U, Uber A, Rettig R: Kidneys from normotensive donors lower blood pressure in young transplanted spontaneously hypertensive rats. Am J Physiol 1997;273:R175-R180.
2. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T: Role of the kidney in primary hypertension: A renal transplantation study in rats. Am J Physiol 1990;258:F606-F611.
3. Hubbard PC, Henderson IW: Renal dopamine and the tubular handling of sodium. J Mol Endocrinol 1995:14:139-155.
4. Jose PA, Raymond JR, Bates MD, Aperia A, Felder RA, Carey RM: The renal dopamine receptors. J Am Soc Nephrol 1992;2:1265-1278.
5. Lee MR: Dopamine and the kidney: Ten years on. Clin Sci (Colch) 1993;84:357-375.
6. Clark BA, Rosa RM, Epstein FH, Young JB, Landsberg L: Altered dopaminergic responses in hypertension. Hypertension 1992;19:589-594.
7. Gill JR Jr, Grossman E, Goldstein DS: High urinary dopa and low urinary dopamine-todopa ratio in salt-sensitive hypertension. Hypertension 1991;18:614-621.
8. Lee MR: Dopamine, the kidney and essential hypertension. Clin Exp Hypertens A 1989; 11(suppl 1):149-158.
9. Saito I, Itsuji S, Takeshita E, Kawabe H, Nishino M, Wainai H, Hasegawa C, Saruta T, Nagano S, Sekihara T: Increased urinary dopamine excretion in young patients with essential hypertension. Clin Exp Hypertens 1994;16:29-39.
10. Hansell P: In vivo evidence for a defect in the dopamine DA1 receptor in the prehypertensive Dahl salt-sensitive rat. Exp Nephrology 1995;3: 15-22.
11. Jose PA, Drago J, Accili D, Eisner GM, Felder RA: Transgenic mice to study the role of dopamine receptors in cardiovascular function. Clin Exp Hypertens 1997;19:15-25.
12. Jose PA, Felder RA: What we can learn from the selective manipulation of dopaminergic receptors about the pathogenesis and treatment of hypertension? Curr Opin Nephrol Hypertens 1996;5:447-451.
13. Kinoshita S, Sidhu A, Felder RA: Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989;84:1849-1856.
14. Mühlbauer B, Osswald H: Feeding-induced increase in urinary dopamine excretion is independent of renal innervation and sodium intake. Am J Physiol 1994;266:F563-F567.
15. Baines AD, Chan W: Production of urine free dopamine from DOPA: A micropuncture study. Life Sci 1980;26:253-259.
16. Chan YL: Cellular mechanisms of renal tubular transport of L-dopa and its derivatives in the rat: Microperfusion studies. J Pharmacol Exp Ther 1976;199:17-24.
17. Hagege J, Richet G: Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int 1985;27:3-8.
18. Goldstein M, Fuxe K, Hökfelt T: Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev 1972; 24:293-309.
19. Hayashi M, Yamaji Y, Kitajima W, Saruta T: Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990;258: F28-F33.
20. +-ATPase activity is inhibited during high-salt diet: Evidence for DA-mediated effect. Am J Physiol 1988; 254:F795-F801.
21. 2 production in rat IMCD cells. II. Possible role for locally formed dopamine. Am J Physiol 1991;261:F655-F662.
22. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987;252:F39-F45.
23. Jose PA, Felder RA, Holloway RR, Eisner GM: Dopamine receptors modulate sodium excretion in denervated kidney. Am J Physiol 1986: 250:F1033-F1038.
24. Takemoto F, Cohen HT, Satoh T, Katz AI: Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron. Pflügers Arch 1992;421:302-306.
25. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. AmJ Physiol 1990;259:F297-F303.
26. Meister B, Bean AJ, Aperia A: Catechol-O-methyltransferase mRNA in the kidney and its appearance during ontogeny. Kidney Int 1993; 44:726-733.
27. Fernandes MH, Soares da Silva P: Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. J Neurol Transm 1994;41(suppl):101-105.
28. +-ATPase. Kidney Int 1997;52:742-747.
29. Hansell P, Odlind C, Männistö PT: Different renal effects of two inhibitors of catechol-O-methylation in the rat: Entacapone and CGP 28014. Acta Physiol Scand 1998;162:489-494.
30. Kaakkola S, Gordin A, Männistö PT: General properties and clinical possibilities of new selective inhibitors of catechol-O-methyltransferase. Gen Pharmacol 1994;25:813-824.
31. Felice LJ, Felice JD, Kissinger PT: Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 1978;31:1461-1465.
32. Nissinen E, Männistö P: Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. Anal Biochem 1984; 137:69-73.
33. Reenilä I, Tuomainen P, Männistö PT: Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1995;663:137-142.
34. Brismar H, Asghar M, Carey RM, Greengard P, Aperia A: Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sdi USA 1998:95:5573-5578.
35. 2 receptors. Am J Physiol 1990;259:F924-F928.
36. Nissinen E, Linden IB, Schultz E, Pohto P: Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor, entacapone. Naunyn Schmiedebergs Arch Pharmacol 1992;346:262-266.
37. Hansell P, Ande'n NE, Grabowska Ande'n M, Ulfendahl HR: Atrial natriuretic factor, urinary catechol compounds and electrolyte excretion in rats during normal hydration and isotonic volume expansion: Influence of dopamine receptor blockade. Acta Physiol Scand 1988;134:421-428.
38. Hansell P, Källskog Ö, Wolgast M: The adrenal glands as suppliers of plasma L-dopa and sources of urinary dopamine. Kidney Blood Press Res 1996;19:109-114.
39. Kinoshita S, Ohlstein EH, Felder RA: Dopamine-1 receptors in rat proximal convoluted tubule: Regulation by intrarenal dopamine. Am J Physiol 1990:258:F1068-F1074.
40. Hughes JM, Ragsdale NV, Felder RA, Chevalier RL, King B, Carey RM: Diuresis and natriuresis during continuous dopamine-1 receptor stimulation. Hypertension 1988;11:I-69-I-74.
41. + antiporter. Acta Physiol Scand 1993;148:55-61.